AC
OCUL icon

AXQ Capital’s Ocular Therapeutix OCUL Stock Holding History

AXQ Capital’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$183K Sell
18,640
-12,015
-39% -$109K 0.02% 741
2026
Q1 		$260K Buy
+30,655
New +$292K 0.03% 643
2025
Q4 		– Sell
-11,517
Closed -$135K – 885
2025
Q3 		$135K Buy
11,517
+797
+7% +$9.53K 0.05% 492
2025
Q2 		$99.5K Buy
+10,720
New +$83.9K 0.03% 518
2023
Q2 		– Sell
-25,972
Closed -$137K – 485
2023
Q1 		$137K Buy
+25,972
New +$123K 0.05% 433

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $161M AUM 27.24% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AXQ Capital's OCUL Position: Q2 2026 in Review

AXQ Capital reduced its Ocular Therapeutix (OCUL) stake by 39% in Q2 2026, selling an estimated $109K and leaving 18,640 shares worth $183K. The position accounts for 0.02% of the portfolio, ranked #741.

AXQ Capital first reported a position in OCUL in Q1 2023 and has held it in 5 quarters since. The position peaked at $260K in Q1 2026. 263 funds tracked by Wall St. Rank hold OCUL as of Q2 2026.

  • AXQ Capital held 18,640 shares of Ocular Therapeutix worth $183K as of Q2 2026.
  • AXQ Capital sold 12,015 Ocular Therapeutix shares in Q2 2026, an estimated $109K.
  • Ocular Therapeutix made up 0.02% of AXQ Capital's portfolio in Q2 2026, its #741 holding.
  • AXQ Capital first reported a position in Ocular Therapeutix in Q1 2023 and has held it in 5 quarters since.
  • AXQ Capital's Ocular Therapeutix position peaked at $260K in Q1 2026.
  • 263 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.